March 28, 2026 - 22:21

Abacus Global Management has announced unprecedented financial and operational results for 2025, citing powerful momentum within the life settlements sector. The firm’s CEO, Jay Jackson, revealed the company achieved year-over-year growth exceeding one hundred percent across several key performance indicators.
Jackson attributed this remarkable performance to strategic portfolio acquisitions and enhanced operational efficiency. He emphasized that the current economic climate, characterized by market volatility and higher interest rates, has increased the attractiveness of life settlements as a non-correlated asset class for institutional investors. This environment has driven significant capital inflows and expanded deal flow.
The company's record year underscores the maturation and increasing acceptance of the life insurance secondary market. Jackson expressed strong confidence in the sector's long-term fundamentals and Abacus Global's strategic position within it. He noted that the firm is well-capitalized and actively pursuing a robust pipeline of new opportunities, aiming to sustain its growth trajectory. The announcement signals a period of exceptional expansion for the firm as it capitalizes on broader industry trends.
March 28, 2026 - 00:54
Coalition urges lawmakers to advance South Carolina Financial Freedom ActA broad coalition of dozens of locally elected officials from across South Carolina is intensifying pressure on state lawmakers to advance a pivotal piece of legislation known as the Financial...
March 27, 2026 - 07:17
Bipartisan group of Senators re-introduces banker ‘clawback’ legislationA significant bipartisan effort is underway in the U.S. Senate to hold senior bank executives personally accountable for failures at their institutions. A group of lawmakers has reintroduced...
March 26, 2026 - 19:52
Rani Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Corporate UpdateRani Therapeutics has unveiled a significant strategic collaboration and provided updates on its innovative oral drug delivery technology. The company has entered into a partnership with Chugai...
March 26, 2026 - 05:23
DA Davidson Reiterates Buy Rating on Axos Financial (AX)Investment firm DA Davidson has reiterated its positive stance on Axos Financial, Inc., maintaining a Buy rating on the stock. The firm also confirmed a price target of $112 per share for the...